Your browser doesn't support javascript.
loading
Sub-group, Sub-type, and Cell-type Heterogeneity of Ependymoma.
Mack, Stephen C; Bertrand, Kelsey C.
Affiliation
  • Mack SC; Baylor College of Medicine, Texas Children's Cancer and Hematology Centers, Dan L. Duncan Cancer Center, Houston, TX 77030, USA. Electronic address: scmack@bcm.edu.
  • Bertrand KC; Baylor College of Medicine, Texas Children's Cancer and Hematology Centers, Dan L. Duncan Cancer Center, Houston, TX 77030, USA.
Cancer Cell ; 38(1): 15-17, 2020 07 13.
Article in En | MEDLINE | ID: mdl-32663463
ABSTRACT
Ependymomas are aggressive central nervous system tumors that resist chemotherapy. In this issue of Cancer Cell, Gojo et al. dissect the single cell transcriptional landscapes of ependymoma to define cellular programs that mediate therapeutic resistance, tumor aggressiveness, and potential targets for therapy.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Central Nervous System Neoplasms / Ependymoma Limits: Child / Humans Language: En Journal: Cancer Cell Journal subject: NEOPLASIAS Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Central Nervous System Neoplasms / Ependymoma Limits: Child / Humans Language: En Journal: Cancer Cell Journal subject: NEOPLASIAS Year: 2020 Type: Article